文献速递肾移植肾小球疾病

人肾移植活检RNA测序解析慢性活动性抗体介导排斥反应的转录组特征

Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
PubMed 文献 · Kidney Int · 2023-11-29

该研究对CA-ABMR、活动性ABMR、TCMR及无排斥反应的肾移植活检组织行RNA测序,鉴定差异表达基因并做通路与免疫细胞分析。结果显示CA-ABMR中NK细胞毒性通路基因集过表达,且分子特征更接近TCMR而非活动性ABMR,免疫组化验证CD56+NK细胞比例更高。

要点

  • CA-ABMR中NK细胞毒性通路基因集过表达,与活动性ABMR不同。
  • CA-ABMR分子特征更接近TCMR,而非活动性ABMR。
  • 免疫组化验证CA-ABMR中CD56+NK细胞比例高于活动性ABMR。

核心结论

  • CA-ABMR以NK细胞毒性通路基因集过表达为特征,且分子上更像TCMR而非活动性ABMR。

研究设计与样本

  • 对人肾移植活检组织行RNA测序,分为CA-ABMR、活动性ABMR、TCMR和无排斥反应四组。
  • 在活检组织中鉴定出15910个基因,并比较各组差异表达基因。

主要发现

  • CA-ABMR、TCMR和活动性ABMR分别有60、114和231个基因独特过表达。
  • 与无排斥反应相比,CA-ABMR与活动性ABMR共享50个过表达基因,与TCMR共享164个。
  • CA-ABMR和TCMR的过表达基因注释到NK细胞和T细胞,活动性ABMR注释到中性粒细胞和单核细胞。
  • 穿孔素、颗粒酶和死亡受体编码基因在CA-ABMR中较活动性ABMR过表达,但与TCMR相比无差异。
  • NK细胞毒性通路基因集变异分析评分在CA-ABMR中高于活动性ABMR,但与TCMR相比无差异。

关键数值与推荐

  • CA-ABMR中NK细胞毒性通路基因集变异分析评分高于活动性ABMR。
  • CA-ABMR中CD56+NK细胞比例高于活动性ABMR。

临床怎么用

  • CA-ABMR的分子特征更接近TCMR,提示NK细胞毒性通路可能参与其发病机制。
  • NK细胞毒性通路基因集和CD56+NK细胞或可作为CA-ABMR与活动性ABMR鉴别的参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Natural killer (NK) cells mediate spontaneous cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity. This dual functionality could enable their participation in chronic active antibody-mediated rejection (CA-ABMR). Earlier microarray profiling studies have not subcategorized antibody-mediated rejection into CA-ABMR and active-ABMR, and the gene expression pattern of CA-ABMR has not been compared with that of T cell-mediated rejection (TCMR). To fill these gaps, we RNA sequenced human kidney allograft biopsies categorized as CA-ABMR, active-ABMR, TCMR, or No Rejection (NR). Among the 15,910 genes identified in the biopsies, 60, 114, and 231 genes were uniquely overexpressed in CA-ABMR, TCMR, and active-ABMR, respectively; compared to NR, 50 genes were shared between CA-ABMR and active-ABMR, and 164 genes between CA-ABMR and TCMR. The overexpressed genes were annotated to NK cells and T cells in CA-ABMR and TCMR, and to neutrophils and monocytes in active-ABMR. The NK cell cytotoxicity and allograft rejection pathways were enriched in CA-ABMR. Genes encoding perforin, granzymes, and death receptor were overexpressed in CA-ABMR versus active-ABMR but not compared to TCMR. NK cell cytotoxicity pathway gene set variation analysis score was higher in CA-ABMR compared to active-ABMR but not in TCMR. Principal component analysis of the deconvolved immune cellular transcriptomes separated CA-ABMR and TCMR from active-ABMR and NR. Immunohistochemistry of kidney allograft biopsies validated a higher proportion of CD56+ NK cells in CA-ABMR than in active-ABMR. Thus, CA-ABMR was exemplified by the overexpression of the NK cell cytotoxicity pathway gene set and, surprisingly, molecularly more like TCMR than active-ABMR.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Shah Y, Yang H, Mueller FB, et al. Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts. Kidney Int. 2023. PMID: 38040290. doi:10.1016/j.kint.2023.11.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。